
The Wall Street Journal @WSJ
Chinese drugmaker CanSino Biologics started trial production of a vaccine using mRNA Technology to target new variants of Covid-19 that are behind the country's current outbreak https://t.co/f5SQh8N4ja — PolitiTweet.org
Created
Sat Jan 07 03:45:03 +0000 2023
Likes
39
Retweets
20
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely AvailableThe Wall Street Journal @WSJ
Chinese drugmaker CanSino Biologics started trial production of a vaccine using mRNA Technology to target new variants of Covid-19 that are behind the country's current outbreak https://t.co/f5SQh8N4ja — PolitiTweet.org